Search the Newsreel

Astera Labs Revenue Grew 93% Last Quarter. The Stock Is Still Down 37% From Its High.

Astera Labs, a semiconductor company focused on AI data center connectivity, reported a 93% year-over-year revenue increase in Q1 2026, reaching $308.4 million. Despite this strong performance, its stock is down 37% from its peak, reflecting broader market volatility and valuation concerns rather than …

Rambus Gains Momentum on Rising AI Memory Bandwidth Needs

Quick Read RMBS fell 28% from its June peak but holds a BUY rating, with a $108.43 base target and bull case reaching $173. Astera Labs trades at a P/E of 283 versus Rambus's forward P/E of 24, while Marvell's hyperscaler demand signals a …

Chip Stocks Enter Bear Market. Astera Labs Continues Slump.

The Philadelphia semiconductor index, known as SOX, fell into bear market territory on Friday. Chip stocks attempted a rebound but failed. Continue Reading

Astera Labs Stock In Shambles: Down 23% With 5-Day Losing Streak

The article reports that Astera Labs stock is experiencing a significant downturn, having fallen 23% and enduring a five-day losing streak. The content provided is minimal and appears to be a stub or an error page rather than a full financial analysis. It mostly …

Astera Labs Is One Misstep Away From A Sharp Re-Rating (NASDAQ:ALAB)

Astera Labs, Inc. (ALAB) carries a 137.3% 12-week semiconductor rally

The weekly trend remains active and relative strength is elevated, while lighter participation leaves confirmation less than complete.

Astera Labs, Inc. (ALAB) Stock Falls Amid Market Uptick: What Investors Need to Know

Astera Labs, Inc. (ALAB) saw its stock decline by 3.08% to $350.62 in the latest session, underperforming the broader market's gains. Despite recent month-long gains for the company, its sector experienced losses. Investors are keenly awaiting Astera Labs' upcoming earnings report, expected on August …

Nasdaq Rallies Despite Chip Selling; Astera Labs, Liquidia, Invesco In Focus | Stock Market Today

The Nasdaq rallied despite a sell-off in chip stocks, with Astera Labs, Liquidia, and Invesco taking center stage. Alissa Coram and Ken Shreve discuss the day's market action and highlight key stocks to watch in this "Stock Market Today" segment. The video content focuses …

Astera Labs Fell 12% Monday. Here’s Where ALAB Stock Could Head in 2026

Astera Labs (ALAB) stock fell 12% due to a broader semiconductor sell-off, despite strong underlying growth and positive management commentary. Analysts maintain cautious ratings due to the stock's premium valuation, with a TIKR valuation model suggesting a potential downside of 21% from its current …

Why Is Astera Labs Stock Falling Monday?

Astera Labs (ALAB) stock is falling on Monday due to a combination of profit-taking, insider stock liquidations by Board Chairman Manuel Alba and Director Stefan Dyckerhoff, and recent index rebalancing. The decline also reflects a global risk-off sentiment in chip stocks and a rotation …

Astera Labs (ALAB) 12-week gain reaches 137.3% in weekly context

The semiconductor connectivity stock is still trending higher, but the latest weekly move came with lighter participation.

Astera Labs (ALAB) keeps active weekly trend as turnover thins

The semiconductor-connectivity stock still carries strong momentum, but lighter volume and a weaker intraday screen make the evidence mixed.

Astera Labs, Inc. (ALAB) 12-week climb reaches 172.7% in weekly context

The semiconductor connectivity stock remains in an active trend, with strong relative strength offset by lighter weekly turnover.

Astera Labs’ 172.7% quarter leads semiconductors, but July’s rebound comes without a volume stamp

ALAB added 3.7% in a weak semiconductor week and remains deep above trend, though participation is running below average and valuation distance is stretched.

Astera Labs, Inc. (ALAB) weekly pullback tests a still-strong semiconductor run

The latest weekly move cut against a strong 52-week trend, with momentum indicators still firm but volume not showing a major expansion.

Aarti Pharmalabs: Can its CDMO bet revive growth after a weak year?

Aarti Pharmalabs expands Xanthine derivatives capacity to 9600 TPA

Astera Labs (ALAB) hits 270.8% twelve-week advance in semiconductor momentum

The cloud and AI infrastructure connectivity chipmaker remains a high-attention Technology mover as weekly strength broadens beyond a single week.

Astera Labs (ALAB) logs 270.8% twelve-week climb as chip tape stays active

The move matters because Astera supplies connectivity chips for cloud and AI infrastructure, a high-attention corner of the semiconductor trade.

Astera Labs (ALAB) marks a 270.8% 12-week semiconductor advance

The cloud and AI connectivity chipmaker remains in weekly focus as momentum indicators stay elevated.

Astera Labs (ALAB) stacks a 216.4% 12-week gain in semiconductors

The cloud and AI connectivity-chip maker remains in an active weekly trend, with participation running only modestly above its recent average.

Astera Labs, Inc. (ALAB) posts a 216.4% 12-week semiconductor rally

The cloud and AI infrastructure chip supplier remains in an active trend as participation runs slightly above its recent weekly norm.

Astera Labs (ALAB) shows 216.4% 12-week advance in weekly context

The semiconductor-connectivity stock remains in focus as AI infrastructure exposure keeps momentum measures elevated.

Astera Labs’ 216% quarter leaves price 207% above Fair Value with only 1.1x volume

Astera Labs remains one of the stronger semiconductor momentum stories, but the latest weekly evidence is more balanced than the price move alone suggests.

Aarti Pharmalabs Insider Ups Holding During Year

Aarti Pharmalabs targets 15-18% revenue and EBITDA growth over 3-4 years

Aarti Pharmalabs uploads Q4FY26 earnings call recording

Aarti Pharmalabs Q4 Results: Shares slide 6% as forex loss, one-offs impact earnings performance

AARTIPHARM Standalone March 2026 Net Sales at Rs 579.70 crore, up 9.46% Y-o-Y

Aarti Pharmalabs Declares Interim Dividend of ₹1.50 Per Share; Record Date Set Today

Unpleasant Surprises Could Be In Store For Aarti Pharmalabs Limited's (NSE:AARTIPHARM) Shares

Aarti Pharmalabs Allots 10,457 Equity Shares Under Performance Stock Option Plan 2023

Aarti Pharmalabs Ltd. Share Price Today - Aarti Pharmalabs Ltd. Stock Price Live NSE/BSE

Here's Why We Think Aarti Pharmalabs (NSE:AARTIPHARM) Might Deserve Your Attention Today

These 4 Measures Indicate That Aarti Pharmalabs (NSE:AARTIPHARM) Is Using Debt Reasonably Well

Aarti Pharmalabs Shares Price Drop 12% on Weak Q2FY26 Earnings